- Home
- CRBP vs TCX Comparison
CRBP vs TCX Comparison
Compare CRBP & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- TCX
- Stock Information
- Founded
- CRBP 2009
- TCX 1992
- Country
- CRBP United States
- TCX Canada
- Employees
- CRBP N/A
- TCX N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- TCX EDP Services
- Sector
- CRBP Health Care
- TCX Technology
- Exchange
- CRBP Nasdaq
- TCX Nasdaq
- Market Cap
- CRBP 233.5M
- TCX 203.7M
- IPO Year
- CRBP N/A
- TCX 1996
- Fundamental
- Price
- CRBP $11.25
- TCX $18.67
- Analyst Decision
- CRBP Strong Buy
- TCX
- Analyst Count
- CRBP 9
- TCX 0
- Target Price
- CRBP $49.00
- TCX N/A
- AVG Volume (30 Days)
- CRBP 561.9K
- TCX 13.1K
- Earning Date
- CRBP 11-07-2025
- TCX 11-06-2025
- Dividend Yield
- CRBP N/A
- TCX N/A
- EPS Growth
- CRBP N/A
- TCX N/A
- EPS
- CRBP N/A
- TCX N/A
- Revenue
- CRBP N/A
- TCX $378,467,000.00
- Revenue This Year
- CRBP N/A
- TCX N/A
- Revenue Next Year
- CRBP $220.00
- TCX N/A
- P/E Ratio
- CRBP N/A
- TCX N/A
- Revenue Growth
- CRBP N/A
- TCX 7.88
- 52 Week Low
- CRBP $4.64
- TCX $13.27
- 52 Week High
- CRBP $20.77
- TCX $23.38
- Technical
- Relative Strength Index (RSI)
- CRBP 32.54
- TCX 51.36
- Support Level
- CRBP $11.59
- TCX $18.07
- Resistance Level
- CRBP $18.11
- TCX $19.17
- Average True Range (ATR)
- CRBP 1.69
- TCX 0.42
- MACD
- CRBP -0.95
- TCX 0.05
- Stochastic Oscillator
- CRBP 0.21
- TCX 56.14
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.